Similar articles

• Dual inhibition of the renin system by aliskiren and valsartan.

  Oparil S, Yarows SA, Patel S, Zhang J, Satlin A. Oparil S, et al. Lancet. 2007 Sep 29;370(9593):1126-7. doi: 10.1016/S0140-6736(07)61508-6. Lancet. 2007. PMID: 17905160 No abstract available.
• Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.

  Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A. Pool JL, et al. Am J Hypertens. 2007 Jan;20(1):11-20. doi: 10.1016/j.amjhyper.2006.06.003. Am J Hypertens. 2007. PMID: 17198906 Clinical Trial.
• The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan.

  Chrysant SG. Chrysant SG. Drugs Today (Barc). 2010 Mar;46(3):151-62. doi: 10.1358/dot.2010.46.3.1437245. Drugs Today (Barc). 2010. PMID: 20467589 Review.
• Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.

  Giles TD, Alessi T, Purkayastha D, Zappe D. Giles TD, et al. J Clin Hypertens (Greenwich). 2012 May;14(5):299-306. doi: 10.1111/j.1751-7176.2012.00608.x. Epub 2012 Mar 16. J Clin Hypertens (Greenwich). 2012. PMID: 22533656 Free PMC article.
• Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.

  Yarows SA. Yarows SA. Expert Rev Cardiovasc Ther. 2010 Jan;8(1):19-33. doi: 10.1586/erc.09.143. Expert Rev Cardiovasc Ther. 2010. PMID: 20030022 Review.